APPLIED THERAPEUTICS INC (APLT)
US03828A1016 - Common Stock
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 98.87M | 49.90M | 16.70M | 53.90M | 57.50M | |||
| Marketable Securities | 253.00K | 254.00K | 13.90M | 26.90M | 39.40M | |||
| Receivables | 262.00K | N/A | N/A | N/A | N/A | |||
| Other Current Assets | 5.22M | 4.23M | 6.70M | 7.60M | 5.80M | |||
| Total Current Assets | 104.60M | 54.39M | 37.30M | 88.40M | 102.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 1.96M | 447.00K | 900.00K | 1.30M | 1.70M | |||
| Other Non-Current Assets | N/A | 0.00 | 200.00K | 200.00K | 200.00K | |||
| Total Non-Current Assets | 1.96M | 447.00K | 1.10M | 1.50M | 1.90M | |||
| TOTAL ASSETS | 106.57M | 54.83M | 38.40M | 89.90M | 104.50M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 12.98M | 15.05M | 15.20M | 16.00M | 20.00M | |||
| Accounts Payable | 2.84M | 1.74M | 4.50M | 9.50M | 600.00K | |||
| Other Current Liabilities | 83.15M | 54.39M | 13.70M | 1.00M | 600.00K | |||
| Total Current Liabilities | 98.97M | 71.18M | 33.40M | 26.50M | 21.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.71M | 797.00K | 900.00K | 900.00K | 1.30M | |||
| Total Non-Current Liabilities | 1.71M | 797.00K | 900.00K | 900.00K | 1.40M | |||
| TOTAL LIABILITIES | 100.67M | 71.98M | 34.30M | 27.40M | 22.60M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -618.22M | -468.59M | -348.80M | -266.30M | -160.70M | |||
| Additional Paid In Capital | 624.10M | 451.43M | 352.80M | 329.00M | 242.80M | |||
| Common Shares | 11.00K | 8.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | N/A | 0.00 | 100.00K | -100.00K | -100.00K | |||
| Shares Outstanding | 116.36M | 84.87M | 48.10M | 26.20M | 22.50M | |||
| Tangible Book Value per Share | 0.05 | -0.20 | 0.09 | 2.39 | 3.64 | |||
| Total Shareholders' Equity | 5.89M | -17.15M | 4.10M | 62.50M | 81.90M | |||
| TOTAL LIABILITIES AND EQUITY | 106.57M | 54.83M | 38.40M | 89.90M | 104.50M | |||
| Statistics | ||||||||
| Current Ratio | 1.06 | 0.76 | 1.12 | 3.34 | 4.84 | |||
| Return On Assets (ROA) | -252.80% | -218.41% | -214.87% | -117.44% | -89.91% | |||
| Return On Equity (ROE) | -4572.20% | N/A | -2012.44% | -168.93% | -114.73% | |||
All data in USD , ROIC based on taxRate of 0.21